Search Results 381-390 of 90858 for Metastasis
A Study of the Safety, Tolerability, Drug/Body Interactions, Biological and Clinical Activity of MSB0011359C (M7824) in Metastatic or Locally Advanced Solid ...
... metastatic colorectal cancer. This study will also explore the accuracy of prediction of pre-existing and newly induced CD8+ T cell responses in each ...
The purpose of this study is to determine whether BNC105P in combination with/following everolimus is effective in the treatment of progressive metastatic clear ...
... metastatic urothelial bladder cancer. This combination, previously reserved for patients ineligible for cisplatin-based chemotherapy, has now become the ...
"The approaches to metastatic and localized prostate cancers are vastly different," says Dr. Childs. "The prognoses vary greatly, and treatment options can ...
This phase II study will test cancer to see if it has a HER2 mutation and, if so, see how HER2 mutated cancer responds to treatment with neratinib.
... (metastatic). In this study, all participants will get either tucatinib ... Symptomatic brain metastasis. Progression of brain metastases since starting ...
When cancer spreads, it's called metastatic cancer. Risk factors. Factors that can increase the risk of sarcoma include: Inherited syndromes. Some syndromes ...
A Study of GDC-0449 and Erlotinib Hydrochloride, with or without Gemcitabine Hydrochloride for Treating Patients with Metastatic Pancreatic Cancer or Solid ...
In time, cancer cells can break away and spread to other parts of the body. When cancer spreads, it's called metastatic cancer. Risk factors. Researchers have ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.